P8-07 QT Interval Prolongation : Project for Database Construction, 1) Standard Protocol, and Inter- and Intra-Facility Differences in APD Assay Using Isolated Guinea Pig Papillary Muscles(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRES
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 2004-10-29
著者
-
Yamamoto Keiji
日本製薬工業協会
-
Sagami Fumio
Qt Prodact
-
Shimosato Takashi
Research Department Nissei Bilis Co. Ltd.
-
TABO Mitsuyasu
Safety Assessment Department, Chugai Pharmaceutical Co., Ltd.
-
Tabo Mitsuyasu
中外製薬
-
Yamamoto Keiji
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
Yamada Masayuki
Clinical Data & Development Management Planning & Management Department Kissei Pharmaceutica
-
TANIGUCHI Shinya
Pharmaceutical Research Laboratories, Ajinomoto Co., Inc.
-
SUGANAMI Hideki
Biostatistics and Data Management Department, Kowa Co., Ltd.
-
YAMAZAKI Ryuzaburo
QT PRODACT
-
KIITANI Shinichi
QT PRODACT
-
KOBAYASHI Kazuo
QT PRODACT
-
SHIMADA Chiaki
QT PRODACT
-
SHIMOSATO Takashi
QT PRODACT
-
TANIGUCHI Shinya
QT PRODACT
-
MORI Tatsuya
QT PRODACT
-
YAMADA Masayuki
Biostatistics and Data Management Subcommittee, Japan Pharmaceutical Manufacturers Association (JPMA
-
YAMAMOTO Keiji
QT PRODACT
-
Kitani Shin-ichi
Pharmacology & Toxicology Department Ina Research Inc.
-
Taniguchi Shinya
Pharmaceutical Research Laboratories Ajinomoto Co. Inc.
-
Yamamoto Keiji
Drug Safety Research Laboratories Tanabe Seiyaku Co. Ltd.
-
Mori Tatsuya
Toxicological Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Kii Yoshihide
Safety Research Laboratories Dainippon Sumitomo Pharma Co. Ltd.
-
Suganami Hideki
Biostatistics And Data Management Department Kowa Co. Ltd.
-
Shimada Chiaki
Research And Development Center Fuso Pharmaceutical Industries Ltd.
-
Yamada Kiyoshi
Pharmaceutical Research Laboratories Toray Industries Inc.
-
Kuriyama Kazuya
Toxicology Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
Suganami Hideki
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
Kiitani Shinichi
Pharmacology & Toxicology Department Ina Research Inc.
-
Shimosato Takashi
Department Of Pharmacology Shiga University Of Medical Sciences
-
Yamazaki Ryuzaburo
Non-clinical Quality Assurance Section Taisho Pharmaceutical Co. Ltd.
-
Kobayashi Kazuo
Pharmacodynamics Research Laboratories Sankyo Co. Ltd.
関連論文
- The predictivity of preliminary embryo-fetal development (EFD) studies : results of a retrospective survey in Japanese pharmaceutical companies
- Mechanism Underlying Endothelium-Dependent Relaxation by 2-Methylthio-ADP in Monkey Cerebral Artery
- Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart
- Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart
- Induction of Hepatic Metallothionein by Trivalent Cerium : Role of Interleukin 6(Pharmacology)
- P8-20 QT Interval Prolongation : Project for Database Construction, 14) Safety Margins of Drug-Induced QT Interval Prolongation: Comparison of Non-Clinical Animal Models and Clinical Data(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESE
- QT-RR RELATIONSHIPS AND SUITABLE QT CORRECTION FORMULAS FOR HALOTHANE-ANESTHETIZED DOGS
- Effects of QT prolongation drugs on the QT interval under pacing condition in anesthetized dogs (CIRCULATORY SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Effects of drugs associated with QT prolongation on monophasic action potential duration in anesthetized guinea-pigs. (CIRCULATORY SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- QT PRODACT : Sensitivity and Specificity of the Canine Telemetry Assay for Detecting Drug-Induced QT Interval Prolongation
- ラットにおけるMMS投与による精巣毒性および精子形態異常の発現について
- P8-02 Effects of E-4031 and Verapamil on electrocardiogram and blood pressure in dogs and Monkeys(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P8-01 Evaluation of QT Prolongation by Holter ECG System for Toxicity Studies in Monkeys(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P11-03 Effects of drugs on respiratory and cardiovascular systems in trained, conscious monkeys : Comparison between indirect and telemetry measurements of blood pressure
- Questionnaire survey on cardiac electrophysiology examination in safety pharmacology studies.(GENERAL SESSION BY POSTER PRESENTATION)(SAFETY PHARMACOLOGY)
- QT PRODACT : Comparison of Non-clinical Studies for Drug-Induced Delay in Ventricular Repolarization and Their Role in Safety Evaluation in Humans
- QT PRODACT : In Vivo QT Assay With a Conscious Monkey for Assessment of the Potential for Drug-Induced QT Interval Prolongation
- QT PRODACT : In Vivo QT Assay in Anesthetized Dog for Detecting the Potential for QT Interval Prolongation by Human Pharmaceuticals
- QT PRODACT : In Vivo QT Assay in the Conscious Dog for Assessing the Potential for QT Interval Prolongation by Human Pharmaceuticals
- QT PRODACT : Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles
- QT PRODACT : Inter- and Intra-facility Variability of the Action Potential Assay Using Isolated Guinea-Pig Papillary Muscles
- QT PRODACT : A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles
- P8-19 QT Interval Prolongation : Project for Database Construction, 13) Species-Difference in Dose-Response Relationship of Drug-Induced QT Interval Prolongation(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of th
- P8-18 QT Interval Prolongation : Project for Database Construction, 12) QT prolongation: Comparison of the sensitivity between canine telemetry assay and isoflurane-anesthetized model(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTAT
- P8-17 QT Interval Prolongation : Project for Database Construction, 11) Evaluation of the drug-induced QT interval change using the individual QT-RR interval relationship in telemetered dogs(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PR
- P8-16 QT Interval Prolongation : Project for Database Construction, 10) Sensitivity to detect drug-induced changes in QT interval for monkey telemetry assay with individual QT-RR correction(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRE
- P8-15 QT prolongation : Project for Database Construction, 9) Individual QT-RR correction and sensitivity to detect drug-induced changes in QT interval for canine telemetry assay(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(
- P8-14 QT Interval Prolongation : Project for Database Construction, 8) Dose (concentration) response analysis of drug-induced QT interval prolongation in anesthetized dogs(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceed
- P8-13 QT interval prolongation : Project for Database Construction, 7) Dose (concentration)-response analysis of drug-induced QT interval prolongation in conscious monkeys(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceed
- P8-12 QT Interval Prolongation : Project for Database Construction, 6) Dose (concentration)-response analysis of drug-induced QT interval prolongation in conscious dogs(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceeding
- P8-11 QT Interval Prolongation : Project for Database Construction, 5) Standard protocol and inter-facility differences in electrocardiographic determination in anesthetized dogs(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(
- P8-10 QT Interval Prolongation : Project for Database Construction, 4) Inter-facility Differences in Electrocardiographic and Hemodynamic Parameters in Telemetered Monkeys(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceed
- P8-09 QT Interval Prolongation : Project for Database Construction, 3) Inter-facility Differences in Electrocardiograhic and Hemodynamic Parameters in Telemetered Dogs(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings
- Collaborative work on evaluation of ovarian toxicity : 2) Two- or four-week repeated dose studies and fertility study of mifepristone in female rats
- Embryonic mortality and intrauterine growth retardation (IUGR) associated with placental alterations in pregnant rats treated with methyl methanesulfonate (MMS) at the peri-implantation stage
- DIFFERENTIAL SUSCEPTIBILITY OF RAT EMBRYOS TO METHYL METHANESULFONATE DURING THE PREGASTRULATION PERIOD
- Prediction of drug-induced QT interval prolongation in telemetered common marmosets
- P8-07 QT Interval Prolongation : Project for Database Construction, 1) Standard Protocol, and Inter- and Intra-Facility Differences in APD Assay Using Isolated Guinea Pig Papillary Muscles(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRES
- Comparison of Endothelium-Related Responses to Nucleotides of Dog and Monkey Cerebral Arteries
- A TIME-COURSE CHARACTERIZATION OF MALE REPRODUCTIVE TOXICITY IN RATS TREATED WITH METHYL METHANESULPHONATE (MMS)
- P-93 Collaborative Work to Evaluate Toxicity on Male Reproductive Organs by Repeaated Dose Studeis in Rats. : 13)Two-week and 4-Week Administration Studies of Methyl Methanesulfonate (MMS).(Proceedings of the 27th Annual Meeting)
- COLLABORATIVE WORK TO EVALUATE TOXICITY ON MALE REPRODUCTIVE ORGANS BY REPEATED DOSE STUDIES IN RATS : 15)TWO-WEEK AND 4-WEEK ADMINISTRATION STUDY OF METHYL METHANESULFONATE(MMS)
- Micronucleus test in rats after oral administration of methyl methanesulfonate for 4 weeks
- P8-08 QT Interval Prolongation : Project for Database Construction, 2) The Usefulness of APD Study in Isolated Guinea Pig Papillary Muscles-Comparison with hERG study and canine Purkinje fiber APD study(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION
- P8-03 In vitro action potential duration assay for assessing the potential for QT interval prolongation : Effects of bepridil on action potentials in guinea-pig papillary muscles(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(
- Effects on embryo-fetal development in rats treated with MMS at the preimplantation stages(Development, Reproduction, Proceedings of the 32nd Annual Meeting)
- Evaluation of Testicular Toxicity and Sperm Morphology in Rats Treated with Methyl Methanesulphonate (MMS)
- QT PRODACT : Inter-facility Variability in Electrocardiographic and Hemodynamic Parameters in Conscious Dogs and Monkeys
- Impairment by Hypoxia or Hypoxia/Reoxygenation of Nitric Oxide–Mediated Relaxation in Isolated Monkey Coronary Artery: the Role of Intracellular Superoxide
- Mechanism Underlying Endothelium-Dependent Relaxation by 2-Methylthio-ADP in Monkey Cerebral Artery
- Comparison of Endothelium-Related Responses to Nucleotides of Dog and Monkey Cerebral Arteries
- Impairment by Hypoxia or Hypoxia/Reoxygenation of Nitric Oxide-Mediated Relaxation in Isolated Monkey Coronary Artery : the Role of Intracellular Superoxide
- Chronic Administration of Nicotine-Free Cigarette Smoke Extract Impaired Endothelium-Dependent Vascular Relaxation in Rats via Increased Vascular Oxidative Stress
- Electrophysiological Characterization of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
- A TIME-COURSE CHARACTERIZATION OF MALE REPRODUCTIVE TOXICITY IN RATS TREATED WITH METHYL METHANESULPHONATE (MMS)
- Beneficial Effect of Intravenous Taurine Infusion on Electroretinographic Disorder in Taurine Deficient Rats.